Schering-Plough
SGP
#508
Rank
C$64.40 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: C$2.85 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of C$2.85 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008C$2.85 B
2006C$2.06 B198.39%
2005C$0.69 B-395.83%
2004-C$0.24 Billion265.22%
2003-C$64.15 Million-102.01%
2002C$3.19 B3.62%
2001C$3.08 B-5.39%
2000C$3.25 B
1998C$2.68 B22.34%
1997C$2.19 B38.9%
1996C$1.58 B